AD Lib

ID: 09940
Title:Understanding Clinical Trials: Putting Data to Good Use for the AD Patient.
Publication Year: 2005.
Format(s): Journal Article , Instructional Package
Language(s): English
Audience(s): Physicians , General Practitioners
Author(s): Caban-Holt, A., et al.
Source: Geriatrics. June 2005 supplement. 20 p.

Abstract: This Continuing Medical Education (CME) activity is designed to update primary care physicians on the clinical management of Alzheimer’s disease (AD). It has three sections. The first section describes assessment tools that are commonly used to measure cognitive, behavioral, functional, and global outcomes in clinical trials, and discusses the implications for evaluating patients in a clinical practice. The second section discusses mild cognitive impairment as a possible preclinical condition for AD and examines the potential for early diagnosis and treatment to disrupt progression to more debilitating stages of the disease. The third section summarizes clinical trial data on therapies, including cholinesterase inhibitors and memantine for the treatment of moderate to severe AD and describes how the evidence-based study results may be interpreted for use in clinical practice. A CME post-test and activity evaluation form (good until June 30, 2006) is included.

Availability: Available from Advanstar Medical Education Resources, Inc. and Advanstar Communications, Inc., publisher of Geriatrics. Corporate Office Advanstar, Inc., One Park Avenue, New York, NY 10016. (800) 225-4569; (212) 951-6600; FAX: (212) 951-6793. E-mail: info@advanstar.com. Website: http://www.geri.com/geriatrics/issue/issueDetail.jsp?id=6461.
Major Descriptor(s): ALZHEIMERS-DISEASE , MILD-COGNITIVE-IMPAIRMENT , EARLY-DEMENTIA , INTERVENTION , DIAGNOSIS , ASSESSMENT-TOOLS , RATING-SCALES , DRUG-THERAPY , MEMANTINE , CHOLINESTERASE-INHIBITORS
Minor Descriptor(s): CLINICAL-TRIALS , CONTINUING-EDUCATION , PRIMARY-CARE-PHYSICIANS

New AD Lib Search